Abstract:It has been documented that methadone maintenance treatment is effective in reducing drug craving and relevant risk behaviors in heroin users. However, it is not understood whether methadone maintenance treatment impairs the dopamine transporter in the striatum. To establish whether chronic opiate use might impair brain dopamine neurons in humans, we assessed dopamine transporter (DAT) uptake function in the striatum (caudate and putamen), and analyzed the correlation between DAT in the striatum and heroin craving and subjective anxiety in former heroin users with prolonged abstinence and in patients receiving methadone maintenance treatment. Binding of [(11)C]-2beta-carbomethoxy-3beta-aryltropane ([(11)C] CFT) as a brain dopamine transporter ligand was measured with positron emission tomography (PET) in eleven former heroin users with prolonged abstinence, ten patients receiving methadone maintenance treatment and ten healthy control subjects. Heroin craving and subjective anxiety in prolonged abstinence and methadone maintenance treatment groups were assessed and the correlations between DAT of striatum and heroin craving or subjective anxiety were determined. In comparison with healthy control subjects, methadone maintenance treatment subjects had lower DAT uptake function in the bilateral caudate and putamen and prolonged abstinence subjects showed significantly lower DAT uptake function in the bilateral caudate. Moreover, in comparison to the prolonged abstinence subjects, the methadone maintenance treatment subjects showed significant decreases of DAT uptake in the bilateral putamen. DAT uptake function in bilateral striatum was not associated with heroin craving in prolonged abstinence or in methadone maintenance treatment subjects; however, DAT uptake function in the bilateral caudate was significantly correlated with subjective anxiety in methadone maintenance treatment subjects. Our findings suggest that chronic opioid use induces long-lasting striatum dopamine neuron impairment, and prolonged withdrawal from opioids can benefit the recovery of impaired dopamine neurons in the brain.

Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers

Decreased dopamine activity predicts relapse in methamphetamine abusers

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Cognitive Function and Nigrostriatal Markers in Abstinent Methamphetamine Abusers

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers

Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high”

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

PET Imaging of Dopamine Transporter and Drug Craving During Methadone Maintenance Treatment and after Prolonged Abstinence in Heroin Users.

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence.

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

Comparison of striatal dopamine transporter levels in chronic heroin‐dependent and methamphetamine‐dependent subjects

Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement

Cocaine abusers do not show loss of dopamine transporters with age

Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users